🇺🇸 FDA
Pipeline program

FPA008

FPA008-002

Phase 2 mab completed

Quick answer

FPA008 for Pigmented Villonodular Synovitis is a Phase 2 program (mab) at Prime Medicine with 1 ClinicalTrials.gov record(s).

Program details

Company
Prime Medicine
Indication
Pigmented Villonodular Synovitis
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials